Ethnic Disparity

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.

Robert A. Winn, MD, FAACR, first called for celebration.

Use of race-neutral/race-free equations to find FEV1 revealed that some Black smokers had more severe COPD than previously found with race-specific equations, according to results published in CHEST.

Compared with the rest of the general public, certain subpopulations in the U.S. tended to seek medical treatment in situations where interventions may be unnecessary, results from a survey study showed.

Most phase 2/phase 3 oncology clinical trials do not report American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander racial categories in their studies, according to findings published in JAMA Health Forum.

The amount of autologous and allogeneic hematopoietic stem cell transplants for hematologic disorders has increased over time in tandem with longer survival, according to results of an observational study.

Native Hawaiian and other Pacific Islander individuals in the United States are two to three times more likely to die of certain cancers than white individuals, according to an American Cancer Society report.

The use of racial-ethnic adjustments in the U.S. version of the Fracture Risk Assessment Tool may be underestimating fractures among underrepresented groups, and new, more accurate tools are needed, according to a task force report.

Cancer Research UK and NCI, through Cancer Grand Challenges, has awarded a 5-year, $25 million grant to Melissa B. Davis, PhD, and global team to address cancer disparities in populations of African descent.

The likelihood for deep sedation on ventilation was heightened among Hispanic vs. non-Hispanic white patients with acute respiratory distress syndrome, according to results published in Annals of the American Thoracic Society.